The authors suggested that liraglutide might have an impact on the renal fibrosis by reducing the activation of TGF-β1/Smad3 (a main mediator of fibrosis) and ERK1/2 (extracellular signal-regulated kinases) signaling pathways [76]. The gene discussed is TGFB1; the disease is renal fibrosis.